Rocky Brands vs Vera Bradley
RCKY and VRA side by side, both in consumer discretionary. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RCKY and VRA compare
Rocky Brands is the larger company, worth 1.8 times as much as Vera Bradley ($388M against $213M).
Rocky Brands grew revenue faster over the last twelve months (9.2% versus −1.7% for Vera Bradley).
Rocky Brands keeps more of each dollar of sales as profit, with a net margin of 5.7% compared with −3.7% at Vera Bradley.
Rocky Brands pays a dividend yielding 1.3%; Vera Bradley does not pay one.
Rocky Brands scores higher on the StockData Score (16 against 9 for Vera Bradley), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RCKY | VRA |
|---|---|---|
| Size and price | ||
| Market cap | $388M | $213M |
| Share price | $51.85 | $7.41 |
| Change, 1 year | 71.0% | 181% |
| Change, 5 years | 44.1% | −25.7% |
| Beta (5Y) | 0.61 | 0.41 |
| Employees | 2,200 | 1,360 |
| StockData Score | ||
| Total score | 16 (better) | 9 |
| Valuation score | 3 (better) | 1 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 1 |
| Health score | 2 | 6 (better) |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 13.6× | – |
| P/S | 0.8× (better) | 0.8× |
| P/B | 1.5× (better) | 1.6× |
| EV/EBITDA | 9.3× | – |
| P/FCF | 23.6× | 7.2× (better) |
| PEG | 6.42 | – |
| FCF yield | 4.2% | 13.8% (better) |
| Fair value | $57.91 | $6.27 |
| Margin of safety | 10.5% (better) | −18.2% |
| Growth | ||
| Revenue growth (TTM) | 9.2% (better) | −1.7% |
| Revenue growth, 5Y average | 11.7% (better) | −10.5% |
| Net income growth (TTM) | 54.9% | – |
| EPS growth (TTM) | 54.0% | – |
| EPS growth, 5Y average | 0.69% | – |
| Profitability | ||
| Gross margin | 42.2% | 50.4% (better) |
| Operating margin | 8.8% (better) | −3.6% |
| Net margin | 5.7% (better) | −3.7% |
| FCF margin | 3.3% | 10.7% (better) |
| Return on equity | 11.5% (better) | −7.4% |
| Return on invested capital | 9.7% (better) | −7.0% |
| Financial health | ||
| Debt / equity | 0.46 (better) | 0.00 |
| Net debt / EBITDA | 2.19 | – |
| Current ratio | 2.97 (better) | 2.44 |
| Altman Z-score | 3.35 | 3.58 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% | – |
| Payout ratio | 16.5% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 2.1% | – |
| Buyback yield | 0.51% | – |
| Shareholder yield | 1.8% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 81.0% | 37.4% |
| Held by insiders | 3.8% | 39.5% |
| Insider net buying, 12 months | −$1.2M | $959K (better) |
| Short interest, % of float | 2.2% | 7.1% |
Go deeper
- RCKY stock overview
- RCKY income statement
- RCKY valuation and score
- VRA stock overview
- VRA income statement
- VRA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.